Intellia Therapeutics, Inc.NTLANASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+14.5%
5Y CAGR+25.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+14.5%/yr
vs +29.4%/yr prior
5Y CAGR
+25.1%/yr
Recent deceleration
Acceleration
-14.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $135.60M | +7.8% |
| 2024 | $125.83M | +8.0% |
| 2023 | $116.50M | +29.0% |
| 2022 | $90.31M | +27.0% |
| 2021 | $71.10M | +61.0% |
| 2020 | $44.17M | +7.6% |
| 2019 | $41.06M | +27.6% |
| 2018 | $32.19M | +14.9% |
| 2017 | $28.02M | +66.8% |
| 2016 | $16.80M | - |